Page Last Updated Feb. 15, 2021 LYS-SAF302 is a gene therapy by Lysogene which is intended to deliver a working copy of the SGSH gene to deliver the gene therapy to the patient's brain. The normal gene is placed inside the shell of a non-disease-causing virus...